Regeneron Pharmaceuticals (REGN)
EBITDA Margin
38.75%
Quarterly · Period ending:
REGN EBITDA Margin
Latest reported38.75%period ending
Latest reported38.75%period ending
REGN Quarterly EBITDA Margin (100.00% → 38.75%)
Quarterly ebitda margin
High-resolution chart · PNG
REGN ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 38.7466% | |
| 26.8292% | |
| 30.9168% | |
| 51.1227% | |
| 45.092% | |
| 34.358% | |
| 28.8979% | |
| 43.7686% | |
| 49.7195% | |
| 26.4197% | |
| 37.239% | |
| 36.6967% | |
| 38.1527% | |
| 30.8498% | |
| 42.2388% | |
| 55.095% | |
| 36.7738% | |
| 38.7508% | |
| 52.3457% | |
| 55.1437% | |
| 74.6969% | |
| 52.7939% | |
| 53.7001% | |
| 47.2493% | |
| 50.584% | |
| 39.9737% | |
| 51.0223% | |
| 47.5541% | |
| 18.0504% | |
| 44.0624% | |
| 37.6755% | |
| 40.8054% | |
| 43.3224% | |
| 41.5614% | |
| 37.6195% | |
| 40.6155% | |
| 38.526% | |
| 36.2326% | |
| 30.1939% | |
| 32.2871% | |
| 26.1133% | |
| 29.3363% | |
| 23.1306% | |
| 36.3186% | |
| 36.0656% | |
| 34.4498% | |
| 28.6588% | |
| 27.1049% | |
| 35.3646% | |
| 31.5577% | |
| 36.5925% | |
| 41.473% | |
| 36.8758% | |
| 37.054% | |
| 37.5859% | |
| 49.6181% | |
| 31.9962% | |
| 13.4722% | |
| -29.8243% | |
| -48.1032% | |
| -47.6941% | |
| -29.3804% | |
| -3.418% | |
| -25.238% | |
| -17.0789% | |
| -23.4271% | |
| -35.0413% | |
| 1.9573% | |
| -14.737% | |
| -24.3488% | |
| -45.9373% | |
| -26.1603% | |
| -27.4974% | |
| -22.9945% | |
| -13.34% | |
| -160.4948% | |
| -124.938% | |
| -195.0469% | |
| -290.837% | |
| -157.1237% | |
| -106.7556% | |
| -98.057% | |
| 1,280.963% | |
| -188.045% | |
| -173.1394% | |
| -151.0395% | |
| 16.7551% | |
| -19.2229% | |
| -35.0165% | |
| 38.3836% | |
| -60.2905% | |
| -126.7652% | |
| -255.7159% | |
| -257.4092% | |
| -663.3754% | |
| -457.021% | |
| -497.7913% | |
| -469.237% | |
| -631.2883% | |
| -397.354% |